The Oncology Institute, Inc. (NASDAQ:TOIIW) Sees Significant Growth in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 3,100 shares, a growth of 19.2% from the November 30th total of 2,600 shares. Based on an average daily trading volume, of 43,000 shares, the short-interest ratio is currently 0.1 days.

Oncology Institute Stock Down 17.4 %

Shares of TOIIW stock opened at $0.01 on Tuesday. Oncology Institute has a one year low of $0.01 and a one year high of $0.37. The stock has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.02.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.